LONDON--(BUSINESS WIRE)--
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 30 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,854,700 |
1.44% |
240,520 |
0.19% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
72,359 |
0.06% |
227,408 |
0.18% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
(4) |
TOTAL: |
|
|
|
|
1,933,159 |
1.50% |
474,028 |
0.37% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities |
Price per unit |
| Purchase | 1 |
229.9700 USD |
| Purchase | 2 |
230.6000 USD |
| Purchase | 4 |
230.7700 USD |
| Purchase | 4 |
232.9700 USD |
| Purchase | 6 |
230.6125 USD |
| Purchase | 7 |
230.2192 USD |
| Purchase | 7 |
230.8600 USD |
| Purchase | 8 |
230.6350 USD |
| Purchase | 9 |
230.6366 USD |
| Purchase | 9 |
230.7500 USD |
| Purchase | 10 |
230.7045 USD |
| Purchase | 11 |
232.1772 USD |
| Purchase | 13 |
230.8700 USD |
| Purchase | 18 |
230.5733 USD |
| Purchase | 19 |
230.6952 USD |
| Purchase | 48 |
231.5771 USD |
| Purchase | 100 |
229.7080 USD |
| Purchase | 100 |
230.6200 USD |
| Purchase | 135 |
231.7635 USD |
| Purchase | 152 |
230.6549 USD |
| Purchase | 198 |
230.6916 USD |
| Purchase | 200 |
230.7350 USD |
| Purchase | 205 |
230.4365 USD |
| Purchase | 300 |
230.4649 USD |
| Purchase | 300 |
231.9066 USD |
| Purchase | 378 |
230.3849 USD |
| Purchase | 421 |
230.8514 USD |
| Purchase | 980 |
230.4013 USD |
| Purchase | 1,149 |
230.5285 USD |
| Purchase | 1,367 |
230.7806 USD |
| Purchase | 1,368 |
230.2302 USD |
| Purchase | 1,476 |
230.5912 USD |
| Purchase | 2,333 |
230.8041 USD |
| Purchase | 2,739 |
230.4859 USD |
| Purchase | 2,848 |
230.7519 USD |
| Purchase | 2,965 |
230.7609 USD |
| Purchase | 2,991 |
230.3006 USD |
| Purchase | 3,035 |
230.7534 USD |
| Purchase | 3,595 |
230.5537 USD |
| Purchase | 3,664 |
230.0355 USD |
| Purchase | 4,282 |
230.0505 USD |
| Purchase | 6,742 |
230.0200 USD |
| Purchase | 19,999 |
230.2736 USD |
| Sale | 7 |
230.7400 USD |
| Sale | 10 |
230.6000 USD |
| Sale | 19 |
230.1700 USD |
| Sale | 33 |
232.0900 USD |
| Sale | 99 |
230.5910 USD |
| Sale | 100 |
230.2300 USD |
| Sale | 100 |
230.0000 USD |
| Sale | 156 |
230.7132 USD |
| Sale | 195 |
230.3887 USD |
| Sale | 205 |
230.4365 USD |
| Sale | 248 |
231.7335 USD |
| Sale | 300 |
231.9066 USD |
| Sale | 339 |
232.2950 USD |
| Sale | 400 |
230.5937 USD |
| Sale | 967 |
230.8579 USD |
| Sale | 1,078 |
230.7394 USD |
| Sale | 1,661 |
230.3214 USD |
| Sale | 2,482 |
230.8063 USD |
| Sale | 2,781 |
230.4954 USD |
| Sale | 3,664 |
230.0355 USD |
| Sale | 3,769 |
230.3064 USD |
| Sale | 11,298 |
230.0200 USD |
| Sale | 23,694 |
230.2923 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 1 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
relates |
|
|
|
||
| Put Options | Purchased | -100 |
220.0000 |
American |
Jul 16, 2021 |
| Call Options | Purchased | 100 |
240.0000 |
American |
Jul 16, 2021 |
| Call Options | Purchased | 6,000 |
220.0000 |
American |
Jul 16, 2021 |
| Put Options | Purchased | -6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.